Business

Retail Offer Launch

Retail Offer Launch.

articleAbingdon Health PlcAugust 19, 20245/company/abingdon-health-plc/news/retail-offer-launch
Retail Offer Launch

About this update from Abingdon Health Plc

[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\nTHE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF ABINGDON HEALTH PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF ABINGDON HEALTH PLC.\n19 AUGUST 2024\n\n\nABINGDON HEALTH PLC\nRetail Offer\n\n\nThe Board of Abingdon Health PLC (the \"Company\") is pleased to announce a retail offer via BookBuild (the \"Retail Offer\") of new ordinary shares (\"Ordinary Shares\") of 0.025 pence each in the capital of the Company (the \"Retail Offer Shares\") to raise up to £500,000 at an issue price of 9.75p per New Ordinary Share (as defined below) (the \"Issue Price\").\nOn 14 August 2024, the Company issued 53,589,741 Placing Shares, raising gross proceeds of £5,224,999.79 at a price of 9.75 pence per New Ordinary Share.\nThe use of proceeds is expected to comprise approximately:\nProduct development                                                          £3.0 million\nAnalytical laboratory service expansion                &nb...

More updates from Abingdon Health Plc